Tri-Solfen 5 mg Solution is a Health Canada–registered veterinary drug (DIN 02528223) held by Dechra Ltd, containing Cetrimide. Health Canada lists its status as Marketed (status date 06 Mar 2023). Nexara Health has matched 34 registrations of Cetrimide across 7 other regulated markets.
Health Canada registration
| DIN | 02528223 |
|---|---|
| Brand name | Tri-Solfen |
| Active ingredient | Cetrimide |
| Strength | 5 mg |
| Dosage form | Solution |
| Route | Topical |
| Company | Dechra Ltd |
| Status | Marketed — 06 Mar 2023 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Cetrimide registered in other markets
34 registrations of the same molecule in 7 national registries outside Canada (first 21 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Bahrain | Topcet | Oman Pharmaceutical Products Co. LLC (Zynova), Oman. | 0.5 % | Cream | POM | NHRA |
| MA | Cetavlon | — | 0.5 G | Creme | P | CNOPS liste des medicaments |
| Malaysia | XORTRIM 2 Cetrimide 2% w/v Lotion | Xorix Sdn Bhd | Non Prescription | PRODUCT APPROVED | NPRA | |
| Saudi Arabia | Cetavlex Cream 0.5%W-W | — | 0.5 | Inactive | SFDA | |
| Taiwan | Cetavlex Antiseptic Cream | Astrazeneca Uk Limited | 乳膏劑 | 已註銷 | TFDA | |
| Taiwan | Cetrim Ointment "Kingdom" | 景德製藥股份有限公司土城工廠 | 軟膏劑 | 已註銷 | TFDA | |
| Taiwan | Cetrimide | Dishman Pharmaceuticals & Chemicals Pvt. Ltd. | （粉） | 已註銷 | TFDA | |
| Taiwan | Cetrimide | Unilab Chemicals & Pharmaceuticals Pvt. Ltd. | （粉） | 已註銷 | TFDA | |
| Taiwan | Cetrimide | DISHMAN Carbogen Amcis LTD. | （粉） | Registered | TFDA | |
| Taiwan | Cetrimide | Unilab Chemicals And Pharmaceuticals Pvt. Ltd. | （粉） | 已註銷 | TFDA | |
| Taiwan | Cetrimide "Delta" | 立大化成工業股份有限公司 | （粉） | 已註銷 | TFDA | |
| Taiwan | Cetrimide "Ravensberg" | Ravensberg Chemische Fabrik GmbH | （粉） | 已註銷 | TFDA | |
| United Arab Emirates | Cetrim Soap | PSYCHOTROPICS INDIA LIMITED, India, Haridwar | 0.50%w/w | Soap | Active | EDE |
| United Kingdom | Cetrimide 0.15% / Chlorhexidine gluconate 0.015% irrigation solution 1litre bottles | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Cetrimide 0.15% / Chlorhexidine gluconate 0.015% irrigation solution 20ml unit dose | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Cetrimide 0.15% / Chlorhexidine gluconate 0.015% irrigation solution 500ml bottles | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Cetrimide 0.2% / Benzalkonium chloride 0.01% cream | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Cetrimide 0.2% / Benzalkonium chloride 0.1% cream | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Cetrimide 0.5% cream | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Cetrimide 0.5% cutaneous spray | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Cetrimide 0.7% / Chlorhexidine gluconate 0.15% solution | — | 0001 | NHS dm+d VMP |
See every manufacturer of Cetrimide worldwide →
Regulator price references for Cetrimide
Published list or reimbursement prices for Cetrimide presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Bahrain | Topcet | 0.5pct | 30G | 0.56 BHD | retail (max) | NHRA | 2026-09-01 |
| MA | Cetavlon | 500mg | 1 TUBE 80 G | 13.80 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| Saudi Arabia | Cetavlex Cream 0.5%W-W | 2.50 SAR | public | SFDA | 2026-09-01 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Tri-Solfen (DIN 02528223) marketed in Canada?
Yes. Health Canada lists DIN 02528223 as Marketed as of 06 Mar 2023.
Who holds the Canadian licence for this product?
Dechra Ltd is the company of record in the Health Canada Drug Product Database.
Is Cetrimide registered outside Canada?
Yes — Nexara Health has matched 34 registrations in 7 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02528223, status date 2023-03-06; national medicine registries: CNOPS liste des medicaments, EDE, NHRA, NHS dm+d VMP, NPRA, SFDA, TFDA; price sources: CNOPS liste des medicaments, NHRA, SFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02528223, status date 2023-03-06; national medicine registries: CNOPS liste des medicaments, EDE, NHRA, NHS dm+d VMP, NPRA, SFDA, TFDA; price sources: CNOPS liste des medicaments, NHRA, SFDA.
Health Canada Drug Product Database (DPD), DIN 02528223, status date 2023-03-06; national medicine registries: CNOPS liste des medicaments, EDE, NHRA, NHS dm+d VMP, NPRA, SFDA, TFDA; price sources: CNOPS liste des medicaments, NHRA, SFDA. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.